PAVmed IncNASDAQ:PAVMNASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.5181
- TODAY'S CHANGE (%)0.0061 (1.1914%)
- Bid / Lots0.5162/ 3
- Ask / Lots0.5200/ 2
- Open / Previous Close0.5000 / 0.5120
- Day Range
- 52 Week Range
- Volume330,355
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | PAVM |
|---|---|---|
| 09:32 ET | 20614 | 0.5 |
| 09:33 ET | 200 | 0.515 |
| 09:42 ET | 9130 | 0.52 |
| 09:44 ET | 12518 | 0.519899 |
| 09:46 ET | 100 | 0.52 |
| 09:48 ET | 11700 | 0.5148 |
| 09:50 ET | 13402 | 0.5239 |
| 09:51 ET | 973 | 0.531675 |
| 09:53 ET | 6544 | 0.511 |
| 09:55 ET | 8073 | 0.5201 |
| 09:57 ET | 13100 | 0.5251 |
| 10:00 ET | 3299 | 0.529799 |
| 10:02 ET | 9456 | 0.5246 |
| 10:04 ET | 800 | 0.5299 |
| 10:06 ET | 200 | 0.52 |
| 10:09 ET | 740 | 0.52 |
| 10:11 ET | 1700 | 0.52 |
| 10:13 ET | 500 | 0.52 |
| 10:18 ET | 800 | 0.52 |
| 10:20 ET | 10100 | 0.52 |
| 10:24 ET | 10100 | 0.524899 |
| 10:26 ET | 5100 | 0.52 |
| 10:27 ET | 6600 | 0.52185 |
| 10:29 ET | 400 | 0.5219 |
| 10:31 ET | 100 | 0.52185 |
| 10:33 ET | 700 | 0.5219 |
| 10:36 ET | 100 | 0.5219 |
| 10:38 ET | 12775 | 0.52 |
| 10:40 ET | 2598 | 0.5247 |
| 10:42 ET | 22617 | 0.5185 |
| 10:44 ET | 4000 | 0.52 |
| 10:49 ET | 300 | 0.51985 |
| 10:51 ET | 2200 | 0.51985 |
| 10:56 ET | 973 | 0.5098 |
| 10:58 ET | 6043 | 0.50981 |
| 11:00 ET | 100 | 0.51985 |
| 11:02 ET | 1200 | 0.524875 |
| 11:03 ET | 300 | 0.5299 |
| 11:05 ET | 125 | 0.5149 |
| 11:09 ET | 100 | 0.52 |
| 11:12 ET | 500 | 0.52 |
| 11:14 ET | 900 | 0.52 |
| 11:16 ET | 5248 | 0.52 |
| 11:18 ET | 700 | 0.52 |
| 11:21 ET | 250 | 0.519751 |
| 11:25 ET | 975 | 0.52 |
| 11:36 ET | 1200 | 0.5199 |
| 11:38 ET | 100 | 0.52 |
| 11:39 ET | 1300 | 0.52 |
| 11:45 ET | 600 | 0.5196 |
| 11:52 ET | 1100 | 0.52 |
| 11:54 ET | 1000 | 0.5199 |
| 12:06 ET | 500 | 0.52 |
| 12:08 ET | 1500 | 0.5199 |
| 12:10 ET | 4504 | 0.5196 |
| 12:14 ET | 200 | 0.52 |
| 12:15 ET | 500 | 0.52 |
| 12:17 ET | 1175 | 0.52 |
| 12:21 ET | 100 | 0.52 |
| 12:33 ET | 2600 | 0.5198 |
| 12:35 ET | 290 | 0.52 |
| 12:42 ET | 800 | 0.5242 |
| 12:44 ET | 500 | 0.5243 |
| 12:46 ET | 650 | 0.5243 |
| 12:50 ET | 11900 | 0.5243 |
| 12:55 ET | 2410 | 0.5287 |
| 12:57 ET | 20301 | 0.5195 |
| 01:02 ET | 800 | 0.52415 |
| 01:04 ET | 1000 | 0.52415 |
| 01:09 ET | 1299 | 0.528599 |
| 01:15 ET | 21885 | 0.5101 |
| 01:18 ET | 500 | 0.5128 |
| 01:24 ET | 1700 | 0.5151 |
| 01:26 ET | 901 | 0.52 |
| 01:27 ET | 700 | 0.52 |
| 01:29 ET | 3866 | 0.52 |
| 01:31 ET | 200 | 0.5199 |
| 01:36 ET | 10100 | 0.519924 |
| 01:38 ET | 5100 | 0.5181 |
Jan 20, 2023
--Cantor Fitzgerald Downgrades PAVmed to Neutral From Overweight, Cuts Price Target to $1.50 From $4, from 8:37AM ET on Friday Jan 20, 2023 by MT Newswires
8:37AM ET on Friday Jan 20, 2023 by MT Newswires
Jan 18, 2023
--Lake Street Adjusts PAVmed's Price Target to $1.50 From $5, Maintains Buy Rating, from 11:13AM ET on Wednesday Jan 18, 2023 by MT Newswires
11:13AM ET on Wednesday Jan 18, 2023 by MT Newswires
Jan 17, 2023
PAVmed, Subsidiaries to Cut 20% of Jobs, Streamline Product Portfolio to Reduce Quarterly Cash Burn, from 4:46PM ET on Tuesday Jan 17, 2023 by MT Newswires
4:46PM ET on Tuesday Jan 17, 2023 by MT NewswiresBRIEF-PAVmed And Lucid Diagnostics Provide Strategic Business Update, from 4:12PM ET on Tuesday Jan 17, 2023 by Thomson Reuters
4:12PM ET on Tuesday Jan 17, 2023 by Thomson ReutersPAVmed and Lucid Diagnostics Provide Strategic Business Update, from 4:05PM ET on Tuesday Jan 17, 2023 by Business Wire
4:05PM ET on Tuesday Jan 17, 2023 by Business Wire
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
PAVmed Inc | 48.0M | -0.5x | --- |
Biosig Technologies Inc | 43.9M | -1.3x | --- |
Movano Inc | 46.1M | -1.7x | --- |
InnerScope Hearing Technologies, Inc. | 42.9M | -0.2x | --- |
Bionoid Pharma Inc | 55.5M | 0.9x | --- |
Optimus Healthcare Services Inc | 55.5M | 0.0x | --- |
Company Information
PAVmed Inc. is a multi-product, commercial-stage medical technology company. The Company operates through four divisions: Medical Devices, Diagnostics, Digital Health and Emerging Innovations. Its Medical Devices division includes CarpX Minimally Invasive Surgical Device for Carpal Tunnel Syndrome, Infusion Therapy - PortIO Implantable Intraosseous Vascular Access Device and NextFlo Disposable Intravenous Infusion Platform Technology. Its Diagnostics division includes EsoGuard Esophageal DNA Laboratory Developed Test, EsoCheck Esophageal Cell Collection Device, and EsoCure Esophageal Ablation Device with Caldus Technology. Its Digital Health division includes Veris cancer healthcare platform and implantable intelligent vascular port combining remote monitoring and data analytics. Its Emerging Innovations division includes NextVent ventilators, FlexMO medical circulatory support cannulas, Veris Cardiac Monitor, DisappEAR resorbable pediatric ear tubes and Solys glucose monitoring.
Contact Information
- Headquarters
- 1 Grand Central Terminal Ste 4600NEW YORK, NY, United States 10017-5743
- Phone
- 212-949-4319
- Fax
- 302-655-5049
Executives
- Chairman of the Board, Chief Executive Officer
- Lishan Aklog
- President, Chief Financial Officer and Corporate Secretary
- Dennis Mcgrath
- Independent Vice Chairman of the Board
- Michael Glennon
- Chief Operating Officer, Executive Vice President
- Shaun O'Neil
- Executive Vice President - Clinical Affairs and Chief Medical Officer
- Brian deGuzman
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $48.0M |
|---|---|
Revenue (TTM) | $565.0K |
Shares Outstanding | 93.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.87 |
EPS | $-1.03 |
Book Value | $0.71 |
P/E Ratio | -0.5x |
Price/Sales (TTM) | 84.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -16,115.40% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
